EAEPCEuropean Association of Euro-Pharmaceutical Companies
References in periodicals archive ?
The Commission's proposal on the counterfeiting of medicines, presented on 21 October to the college of commissioners, could, according to the EAEPC, put the activity of parallel trade in jeopardy, even though it is perfectly legal in the EU, explained the association, on 19 November, particularly regarding the traceability of medicines and repackaging.
It is a certain favouritism for the pharmaceutical industry which the billowing voice of the EAEPC suspects and denounces today.
The EAEPC admits to having doubts over the proposals which will come out on 26 November.
If this idea [thematic focus on trade] materialises [ ], if the Commission gives in on that point, it must keep the promise it made to us concerning our participation," an EAEPC representative said.
Pfizer is a heavyweight in Spain, but its actions are not limited to the Spanish market: they foreshadow the company's intentions to exert control over distribution in other EU member states, not least Germany where Pfizer is considering a system of direct sales which would squeeze out wholesalers altogether, according to the EAEPC.
The EAEPC concludes that parallel distribution of patented medicines can generate significant savings for governments, taxpayers and patients.
The EAEPC study* underlines the fact that the EU Court of Justice has never settled this highly controversial issue.
But EAEPC says that parallel imports provide the only form of price competition when it comes to innovative, patent-protected drugs: "Parallel trade in medicines is a good example of how the EU Single Market can deliver savings to consumers, health insurers and governments.